New 13D33
New 13G65
Stated intents0
The week of 2026-08-17, 33 holders filed a new Schedule 13D and 65 a new Schedule 13G reporting 5% or more of a company, and 0 13D filings stated in Item 4 an intent to influence the company. Open a company for every holder and the purpose each 13D states, quoted.
New Schedule 13D
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-08-17 | Hwh International Inc. | Liu Ming Hui | 94.8% | SCHEDULE 13D |
| 2026-08-18 | Suja Life, Inc. | Paine Schwartz Food Chain Fund V GP, Ltd. | 62.77% | SCHEDULE 13D |
| 2026-08-19 | Profusa, Inc. | NorthView Sponsor I, LLC | 49.9% | SCHEDULE 13D |
| 2026-08-18 | Advasa Holdings, Inc. | Kosugi Asamitsu | 47.76% | SCHEDULE 13D |
| 2026-08-21 | Air Water Ventures Ltd | Inflection Point Asset Management LLC | 40.5% | SCHEDULE 13D |
| 2026-08-20 | Dogness (International) Corporation | Fuxing Yang | 35.67% | SCHEDULE 13D |
| 2026-08-19 | OceanLight Acquisition Corp | OceanLight Capital Sponsor Ltd | 33.53% | SCHEDULE 13D |
| 2026-08-19 | Futurewave Acquisition Corp | Futurewave Capital Solutions Ltd | 30.8% | SCHEDULE 13D |
| 2026-08-17 | Pinnacle Acquisition Corp | Steven Kenneth Hudson | 27.82% | SCHEDULE 13D |
| 2026-08-18 | Advasa Holdings, Inc. | Tatsuya Akimoto | 27.81% | SCHEDULE 13D |
| 2026-08-18 | SunScout Holding Ltd | Cywinski Friedrich Edwin | 27.5% | SCHEDULE 13D |
| 2026-08-17 | Pinnacle Acquisition Corp | Andrew Rechtschaffen | 26.85% | SCHEDULE 13D |
| 2026-08-18 | Katapult Holdings, Inc. | BasePoint Group Inc. | 26.8% | SCHEDULE 13D |
| 2026-08-19 | Pelican Acquisition II Corp | Pelican II Capital Solutions Ltd | 26.36% | SCHEDULE 13D |
| 2026-08-18 | SunScout Holding Ltd | Cywinski Marc | 23.2% | SCHEDULE 13D |
| 2026-08-17 | Pinnacle Acquisition Corp | PAC Sponsor, LLC | 23% | SCHEDULE 13D |
| 2026-08-18 | Katapult Holdings, Inc. | William Allan Jones | 21.8% | SCHEDULE 13D |
| 2026-08-17 | Jewett Cameron Trading Co Ltd | Kotarba Partners Fund I, LP | 20.98% | SCHEDULE 13D |
| 2026-08-18 | Braveheart Bio, Inc. | Orbimed Advisors LLC | 17.2% | SCHEDULE 13D |
| 2026-08-17 | Latigo Biotherapeutics, Inc. | Foresite Capital Fund VI LP | 14.5% | SCHEDULE 13D |
| 2026-08-17 | Latigo Biotherapeutics, Inc. | Foresite Capital Fund VI LP | 14.5% | SCHEDULE 13D |
| 2026-08-20 | Addentax Group Corp. | Hong Zhiwang | 10.7% | SCHEDULE 13D |
| 2026-08-17 | Femasys Inc | Nantahala Capital Partners Limited Partnership | 9.99% | SCHEDULE 13D |
| 2026-08-20 | Super League Enterprise, Inc. | Evo Fund | 9.9% | SCHEDULE 13D |
| 2026-08-20 | Group 1 Automotive, Inc. | Conifer Management, L.L.C. | 9.7% | SCHEDULE 13D |
| 2026-08-18 | HeartSciences Inc. | Digital Currency Group, Inc. | 9.4% | SCHEDULE 13D |
| 2026-08-18 | BlossomHill Therapeutics, Inc. | Orbimed Advisors LLC | 8.9% | SCHEDULE 13D |
| 2026-08-21 | Jin Medical International Ltd. | Wang Erqi | 6.77% | SCHEDULE 13D |
| 2026-08-21 | Cue Biopharma, Inc. | Shao-Lee Lin | 6.2% | SCHEDULE 13D |
| 2026-08-20 | Hepion Pharmaceuticals, Inc. | Gary Stetz | 5.7% | SCHEDULE 13D |
| 2026-08-20 | Hepion Pharmaceuticals, Inc. | Sireesh Appajosyula | 5.7% | SCHEDULE 13D |
| 2026-08-21 | Immersion Corp | Singer Eric | 5.5% | SCHEDULE 13D |
| 2026-08-18 | Conexeu Sciences Inc. | Jeffrey Sharpe | 5.4% | SCHEDULE 13D |
New Schedule 13G
| Filed | Company | Holder | Percent | Filing |
|---|---|---|---|---|
| 2026-08-19 | Fort Technology Inc | Nexera Technologies Ltd | 72.53% | SCHEDULE 13G |
| 2026-08-18 | Gores Holdings XI, Inc. | Gores Sponsor XI LLC | 20.3% | SCHEDULE 13G |
| 2026-08-19 | DSC Holdings Ltd. | Ant Group Co., Ltd. | 18.4% | SCHEDULE 13G |
| 2026-08-19 | iOThree Limited | Jun Li | 16.3% | SCHEDULE 13G |
| 2026-08-17 | Aeon Acquisition I Corp. | Polar Asset Management Partners Inc. | 13.6% | SCHEDULE 13G |
| 2026-08-21 | AEON Biopharma, Inc. | Timothy P. Lynch | 13% | SCHEDULE 13G |
| 2026-08-20 | Advanced Biomed Inc. | Pau Hung To | 12.75% | SCHEDULE 13G |
| 2026-08-17 | Kartoon Studios Inc | Clear Street Derivatives LLC | 12% | SCHEDULE 13G |
| 2026-08-20 | Addentax Group Corp. | Hong Zhihao | 11.88% | SCHEDULE 13G |
| 2026-08-20 | Addentax Group Corp. | Pinnacle Partners Inc. | 11.88% | SCHEDULE 13G |
| 2026-08-20 | Swarmer, Inc | RG.AI Technologies, Inc. | 10.98% | SCHEDULE 13G |
| 2026-08-18 | Jin Medical International Ltd. | Novastralist Horizon Ltd. | 10.46% | SCHEDULE 13G |
| 2026-08-18 | Addentax Group Corp. | Seah Chia Yee | 10.3% | SCHEDULE 13G |
| 2026-08-17 | Borr Drilling Ltd | cobas asset management, sgiic, s.a. | 10.2% | SCHEDULE 13G |
| 2026-08-17 | Achieve Life Sciences, Inc. | Logos Global Management LP | 9.99% | SCHEDULE 13G |
| 2026-08-21 | Catheter Precision, Inc. | C/M Capital Partners, LP | 9.99% | SCHEDULE 13G |
| 2026-08-20 | 22nd Century Group | Joseph Reda | 9.97% | SCHEDULE 13G |
| 2026-08-17 | Jasper Therapeutics, Inc. | Velan Capital Investment Management LP | 9.9% | SCHEDULE 13G |
| 2026-08-18 | Edgemode, Inc. | Clearthink Capital Partners, LLC | 9.9% | SCHEDULE 13G |
| 2026-08-19 | Outlook Therapeutics, Inc. | CVI Investments, Inc. | 9.9% | SCHEDULE 13G |
| 2026-08-20 | 22nd Century Group | Schechter Jonathan | 9.9% | SCHEDULE 13G |
| 2026-08-17 | Gran Tierra Energy Inc. | Equinox Partners Investment Management LLC | 9.8% | SCHEDULE 13G |
| 2026-08-21 | Nano Dimension Ltd. | Tang Capital Management, LLC | 9.1% | SCHEDULE 13G |
| 2026-08-19 | iOThree Limited | YR Sea Group Pte. Ltd. | 8.72% | SCHEDULE 13G |
| 2026-08-17 | Thunder Bridge Capital Partners V, Ltd. | MMCAP International Inc. SPC | 8.5% | SCHEDULE 13G |
| 2026-08-20 | GoPro, Inc. | Fischbach Mark Edward | 8.5% | SCHEDULE 13G |
| 2026-08-17 | Latigo Biotherapeutics, Inc. | RA Capital Management, L.P. | 8.4% | SCHEDULE 13G |
| 2026-08-19 | Biovie Inc. | Alta Partners LLC | 8.4% | SCHEDULE 13G |
| 2026-08-21 | iOThree Limited | PT Vox Inovasi Nusantara | 8.34% | SCHEDULE 13G |
| 2026-08-21 | Royalty Management Holding Corp | First Frontier Capital LLC | 8.2% | SCHEDULE 13G |
| 2026-08-20 | Mayfair Gold Corp. | Oaktree Capital Management, L.P. | 8.19% | SCHEDULE 13G |
| 2026-08-18 | Advasa Holdings, Inc. | Taiji Ito | 8.13% | SCHEDULE 13G |
| 2026-08-18 | Conexeu Sciences Inc. | David Bogart | 8.1% | SCHEDULE 13G |
| 2026-08-18 | PSB Financial, Inc. | PSB Financial, Inc. Employee Stock Ownership Plan Trust | 8% | SCHEDULE 13G |
| 2026-08-19 | C3is Inc. | Jane Street Group, LLC | 7.2% | SCHEDULE 13G |
| 2026-08-20 | Charter Communications, Inc. | Ronald A. Duncan | 6.6% | SCHEDULE 13G |
| 2026-08-20 | Thunder Bridge Capital Partners V, Ltd. | Linden Capital L.P. | 6.3% | SCHEDULE 13G |
| 2026-08-19 | Tidal Trust II | Vencl William John Jr | 6.2% | SCHEDULE 13G |
| 2026-08-20 | GMR Solutions Inc. | North Peak Capital Management, LLC | 6.2% | SCHEDULE 13G |
| 2026-08-21 | Lincoln National Corp | BlackRock, Inc. | 6.2% | SCHEDULE 13G |
| 2026-08-19 | RxSight, Inc. | Point72 Asset Management, L.P. | 6% | SCHEDULE 13G |
| 2026-08-21 | Royalty Management Holding Corp | White River Ventures LLC | 6% | SCHEDULE 13G |
| 2026-08-19 | Stereotaxis, Inc. | Daniel Louis Kaufman | 5.9% | SCHEDULE 13G |
| 2026-08-21 | Micropolis AI Robotics | Alexander Rugaev | 5.9% | SCHEDULE 13G |
| 2026-08-18 | Tenax Therapeutics, Inc. | Millennium Management LLC | 5.8% | SCHEDULE 13G |
| 2026-08-18 | Processa Pharmaceuticals, Inc. | Soleus Capital Master Fund, L.P. | 5.8% | SCHEDULE 13G |
| 2026-08-19 | Grocery Outlet Holding Corp. | Pertento Partners LLP | 5.6% | SCHEDULE 13G |
| 2026-08-19 | Vanda Pharmaceuticals Inc. | Millennium Management LLC | 5.6% | SCHEDULE 13G |
| 2026-08-17 | BlossomHill Therapeutics, Inc. | Vivo Innovation Fund II Holdings, L.P. | 5.5% | SCHEDULE 13G |
| 2026-08-19 | T1 Energy Inc. | Millennium Management LLC | 5.5% | SCHEDULE 13G |
| 2026-08-20 | MapLight Therapeutics, Inc. | Nan Fung Group Holdings Limited | 5.5% | SCHEDULE 13G |
| 2026-08-17 | KKR Real Estate Finance Trust Inc. | Terra Capital Partners, LLC | 5.4% | SCHEDULE 13G |
| 2026-08-21 | CDT Equity Inc. | Primary Development Fund (Cayman) SPC | 5.3% | SCHEDULE 13G |
| 2026-08-20 | Black Stone Minerals, L.P. | Morgan Stanley | 5.2% | SCHEDULE 13G |
| 2026-08-19 | AVAX One Technology Ltd. | Saba Capital Management, L.P. | 5.11% | SCHEDULE 13G |
| 2026-08-17 | InflaRx N.V. | Commodore Capital LP | 5.1% | SCHEDULE 13G |
| 2026-08-18 | Cellebrite DI Ltd. | Voss Capital, LP | 5.1% | SCHEDULE 13G |
| 2026-08-20 | Rank One Computing Corp | Laurence W. Lytton | 5.1% | SCHEDULE 13G |
| 2026-08-20 | Redwood Trust Inc | Bay Pond Investors (Bermuda) L.P. | 5.1% | SCHEDULE 13G |
| 2026-08-21 | CDT Environmental Technology Investment Holdings Ltd | Jane Street Group, LLC | 5.1% | SCHEDULE 13G |
| 2026-08-17 | Hancock Park Corporate Income, Inc. | Orchard First Source Asset Management Holdings, LLC | 5.02% | SCHEDULE 13G |
| 2026-08-17 | Groupon, Inc. | Millennium Management LLC | 5% | SCHEDULE 13G |
| 2026-08-18 | Latigo Biotherapeutics, Inc. | AI Biotechnology LLC | 5% | SCHEDULE 13G |
| 2026-08-20 | Viridian Therapeutics, Inc. | Point72 Asset Management, L.P. | 5% | SCHEDULE 13G |
| 2026-08-21 | Neo-Concept International Group Holdings Ltd | Jane Street Group, LLC | 5% | SCHEDULE 13G |
Stated intent
No 13D this week stated an intent to influence the company.
Download this data (CSV)98 rows, with sources
Tools for this story
Each opens in a new tab. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.